11320sek
-4,0 %
Date:2024-05-02Time:17:29:41Latest report:Q4-2023List:Mid CapTicker:BIOG B
Market Cap:11 431 msekEnterprise Value:9 887 msekNet Sales:1 297 msekEarnings:365,4 msekEmployees:0ISIN:SE0017769995

Ratios

10-year key figure history for BioGaia turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for BioGaia with index and moving average MA50 and MA200.

Stockprice:113,20
MA50:123,14
MA200:108,55
Price/MA200:4,3 %
RSI (14):37,8
Price/MA50:-8,1 %

Description

BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.